Our research groups contribute to one or more of the Centre's strategic research domains.
Co-Leads: Professor Simon Laws and Dr Tenielle Porter
We investigate genetic risk and progression, gene-lifestyle interactions, prediction of treatment response and genetic correlates of brain health and comorbidities, particularly in Alzheimer's Disease. We also provide genetic analysis support to external academic and industry partners through both collaborative engagement and service options.
Group Lead: Professor Elin Gray
Our research focuses on developing non-invasive, blood-based tests (liquid biopsies) for melanoma, to enable personalised cancer monitoring and guide treatment decisions. We aim to discover new treatment targets through the application of innovative cutting-edge technologies, to support more precise and effective melanoma care.
Group Lead: Professor Joanne Dickson
Our research focuses on understanding the nature of adaptive and maladaptive psychological mechanisms implicated in maintaining and promoting mental health. We develop interventions designed to promote mental health and quality of life, and explore how mental health may impact a variety of health conditions.
Group Lead: Dr Christopher Latella
Our Laboratory houses state-of-the-art brain and nerve stimulation and recording equipment. We specialise in transcranial magnetic stimulation, high-density electromyography, and intermittent hypoxia, among other techniques that help us understand mechanisms of motor system function (or dysfunction) in health and disease.
Group Lead: Dr Vivian Chua
Our research projects aim to uncover novel therapeutic targets and biomarkers that are important in the biology of cancers including tumour growth, metastasis and response to therapies, with a special focus on uveal melanoma.
Group Lead: Dr Pauline Zaenker
The link between autoimmunity and cancer is well documented and autoantibodies are emerging as promising cancer biomarkers. With a track record of >10 years in this area, we are amongst the leaders in this vastly evolving research field.
Group Lead: Dr Aaron Beasley
Cancer genomics research aims to improve the clinical care of cancer patients. Our cutting-edge approaches aim to discover therapeutic targets, treatment resistance, and biomarker implementation across the spectrum of cancer management from risk of cancer metastases to management of late-stage disease.